G
Guggenheim Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
251 |
251
Merck
MRK
$212B
|
SF
Seamus Fernandez
| $84.71 | $122 |
44%
upside
| Buy | 7 months ago |
|
252 |
252
Acadia Pharmaceuticals
ACAD
$4.26B
|
YS
Yatin Suneja
| $25.26 | $20 |
21%
downside
| Neutral | 8 months ago |
|
253 |
253
VF Corp
VFC
$5.86B
|
RD
Robert Drbul
| $15 | $27 |
80%
upside
| Buy | 9 months ago |
|
254 |
254
G-III Apparel Group
GIII
$1.12B
|
RD
Robert Drbul
| $25.96 | $38 |
46%
upside
| Buy | 9 months ago |
|
255 |
255
lululemon athletica
LULU
$19.9B
|
RD
Robert Drbul
| $167.80 | $415 |
147%
upside
| Buy | 9 months ago |
|
256 |
256
PVH
PVH
$4.22B
|
RD
Robert Drbul
| $87.76 | $125 |
42%
upside
| Buy | 9 months ago |
|
257 |
257
TJX Companies
TJX
$155B
|
RD
Robert Drbul
| $139.26 | $140 |
1%
upside
| Buy | 9 months ago |
|
258 |
258
Foot Locker
FL
$2.29B
|
RD
Robert Drbul
| $24.01 | $28 |
17%
upside
| Buy | 9 months ago |
|
259 |
259
Prime Medicine
PRME
$663M
|
DC
Debjit Chattopadhyay
| $3.72 | $18 |
384%
upside
| Buy | 9 months ago |
|
260 |
260
Benitec Biopharma
BNTC
$365M
|
DC
Debjit Chattopadhyay
| $13.91 | $17 |
22%
upside
| Buy | 9 months ago |
|
261 |
261
Ross Stores
ROST
$49.4B
|
RD
Robert Drbul
| $150.95 | $180 |
19%
upside
| Buy | 9 months ago |
|
262 |
GAP
262
The Gap, Inc.
GAP
$8.83B
|
RD
Robert Drbul
| $23.80 | $35 |
47%
upside
| Buy | 9 months ago |
|
263 |
263
Chesapeake Utilities
CPK
$2.96B
|
SP
Shahriar Pourreza
| $125.58 | $129 |
3%
upside
| Neutral | 9 months ago |
|
264 |
264
Madison Square Garden
MSGE
$1.94B
|
CB
Curry Baker
| $40.86 | $48 |
17%
upside
| Buy | 9 months ago |
|
265 |
265
Tango Therapeutics
TNGX
$772M
|
CZ
Charles Zhu
| $6.94 | $8 |
15%
upside
| Buy | 10 months ago |
|
266 |
266
Sarepta Therapeutics
SRPT
$1.96B
|
WI
Whitney Ijem
| $18.71 | $150 |
702%
upside
| Buy | 10 months ago |
|
267 |
267
Performance Food Group
PFGC
$16.5B
| $105.42 | $95 |
10%
downside
| Buy | 10 months ago |
|
|
268 |
268
Amicus Therapeutics
FOLD
$2.46B
|
DC
Debjit Chattopadhyay
| $7.99 | $15 |
88%
upside
| Buy | 10 months ago |
|
269 |
269
Kymera Therapeutics
KYMR
$3.11B
| $43.51 | $52 |
20%
upside
| Buy | 10 months ago |
|
|
270 |
270
Entergy
ETR
$39.2B
|
SP
Shahriar Pourreza
| $87.75 | $82.50 |
6%
downside
| Buy | 10 months ago |
|
271 |
271
Kontoor Brands
KTB
$4.46B
|
RD
Robert Drbul
| $80.24 | $100 |
25%
upside
| Buy | 10 months ago |
|
272 |
272
Revolution Medicines
RVMD
$7.57B
|
MS
Michael Schmitz
| $40.50 | $82 |
102%
upside
| Buy | 10 months ago |
|
273 |
273
Spyre Therapeutics
SYRE
$1.03B
|
YS
Yatin Suneja
| $17 | $65 |
282%
upside
| Buy | 10 months ago |
|
274 |
274
Tesla
TSLA
$1.13T
| $350.84 | $156 |
56%
downside
| Sell | 10 months ago |
|
|
275 |
275
McDonald's
MCD
$224B
|
GF
Gregory Francfort
| $314.38 | $285 |
9%
downside
| Neutral | 10 months ago |
|